Europe — EMA
Aprepitant Viatris
Aprepitant Viatris is an antiemetic medication used to prevent nausea and vomiting caused by chemotherapy. This oral medication is manufactured by Viatris Sante
Request sourcing
What is Aprepitant?
Aprepitant Viatris is an antiemetic medication used to prevent nausea and vomiting caused by chemotherapy. This oral medication is manufactured by Viatris Sante and is available in the EU market.
What is Aprepitant used for?
Aprepitant Viatris is primarily used to prevent nausea and vomiting in patients undergoing chemotherapy. It works by blocking substances in the body that can trigger these symptoms. This medication is often prescribed to improve the quality of life for patients receiving cancer treatment.
What are the side effects of Aprepitant?
Common effects of Aprepitant Viatris may include fatigue, headache, and constipation. Some users might experience dizziness or diarrhea. These effects vary among individuals and are generally mild to moderate in nature.
What precautions apply to Aprepitant?
Aprepitant Viatris should be used with caution in patients with liver problems. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking.
What does Aprepitant interact with?
Aprepitant Viatris may interact with other medications, including those metabolized by the liver. It is advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare professional before combining Aprepitant Viatris with other treatments.
